Ryvu announces option to license inflammation program exercised by Galapagos NV

/PRNewswire/ -- Ryvu Therapeutics S.A. (WSE: RVU) announced today that the pre-agreed criteria in the Option, License and Research Collaboration Agreement,...

Related Keywords

Poland ,Warsaw ,L67 , ,Research Collaboration Agreement ,Warsaw Stock Exchange ,Vatnak Vat Ho ,Chief Business Officer ,Ryvu Therapeutics ,